Walgreens tackles declining profits, store closures, and rising costs. Learn about Sycamore Partners' acquisition offer of ...

Adjusted earnings came in at $0.63 per share for the three-month period ended Feb. 28, exceeding analyst expectations of ...

The company is in the process of being taken private by Sycamore Partners in a deal that is expected to close in the fourth ...

Walgreens Boots Alliance, Inc. (Nasdaq: WBA) today announced financial results for the second quarter of fiscal 2025, which ended February 28, 2025.

Cencora, Inc. COR is well-poised for growth on the back of robust U.S. Healthcare Solutions business and product launches.

Renewed collaborations with Express Scripts and Walgreens strengthen core distribution capabilities and align resources to meet customer needs effectively. Cencora operates in a highly competitive ...

There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Edgewise Therapeutics (EWTX – Research Report), ...

February 7, 2025 Walgreens sells more shares in Cencora; cuts stake to 6% U.S. drugstore chain Walgreens Boots Alliance said on Thursday it has sold more shares in drug distributor Cencora for ...

Pharmaceutical companies accused of fueling the nation's opioid crisis are paying state and local governments billions of ...

Walgreens Cashes In: Slashes Cencora Stake Again In Debt-Fighting Move ...